Brad L. Steenwyk

Argatroban, Bivalirudin, and Lepirudin do not Decrease Clot Propagation and Strength as Effectively as Heparin-activated Antithrombin In Vitro

Vance G. Nielsen, Brad L. Steenwyk, William Q. Gurley et al. · The Journal of Heart and Lung Transplantation · 2006 · 51 citations

Thrombosis, Heparin-activated Antithrombin, Medicine +11

Decreasing the Preincision Time for Pulmonary Lobectomy: The Process of Lean and Value Stream Mapping

Robert J. Cerfolio, Brad L. Steenwyk, Caroline Watson et al. · The Annals of Thoracic Surgery · 2015 · 37 citations · Full text

Value Stream Mapping, Pulmonary Lobectomy, Interventional Pulmonology +10

Qualitative Thrombelastographic Detection of Tissue Factor in Human Plasma

Vance G. Nielsen, Paul Audu, Lana Cankovic et al. · Anesthesia & Analgesia · 2006 · 34 citations

ε-Aminocaproic acid inhibition of fibrinolysis in vitro: should the ‘therapeutic’ concentration be reconsidered?

Vance G. Nielsen, Lana Cankovic, Brad L. Steenwyk · Blood Coagulation & Fibrinolysis · 2006 · 33 citations

Pharmaceutical Science, Pharmacotherapy, Thrombosis +17

Contact Activation Prolongs Clot Lysis Time in Human Plasma: Role of Thrombin-activatable Fibrinolysis Inhibitor and Factor XIII

Vance G. Nielsen, Brad L. Steenwyk, William Q. Gurley · The Journal of Heart and Lung Transplantation · 2006 · 26 citations

Inflammation, Thrombosis, Thrombopoiesis +13